Acquired Company
Bristol Myers Squibb acquired Karuna Therapeutics for $330.00 per share in cash, for a total equity value of approximately $14.0 billion.
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts. Show more
99 HIGH STREET, BOSTON, MA, UNITED STATES, 02110, USA
Market Cap
12.6B
52 Wk Range
$0.00 - $0.00
Previous Close
$329.83
Open
$329.83
Volume
N/A
Day Range
$329.83 - $329.83
Enterprise Value
0.00
Cash
185.8M
Avg Qtr Burn
-111.1M
Insider Ownership
4.99%
Institutional Own.
86.32%
Qtr Updated
12/31/23
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|